These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Why is chronic kidney disease progressive? Evolutionary adaptations and maladaptations. Chevalier RL Am J Physiol Renal Physiol; 2023 Nov; 325(5):F595-F617. PubMed ID: 37675460 [TBL] [Abstract][Full Text] [Related]
6. Impact of early life development on later onset chronic kidney disease and hypertension and the role of evolutionary trade-offs. Luyckx VA; Chevalier RL Exp Physiol; 2022 May; 107(5):410-414. PubMed ID: 35037332 [TBL] [Abstract][Full Text] [Related]
11. Evo-devo perspectives on cancer. Nedelcu AM Essays Biochem; 2022 Dec; 66(6):797-815. PubMed ID: 36250956 [TBL] [Abstract][Full Text] [Related]
12. A way forward with eco evo devo: an extended theory of resource polymorphism with postglacial fishes as model systems. Skúlason S; Parsons KJ; Svanbäck R; Räsänen K; Ferguson MM; Adams CE; Amundsen PA; Bartels P; Bean CW; Boughman JW; Englund G; Guðbrandsson J; Hooker OE; Hudson AG; Kahilainen KK; Knudsen R; Kristjánsson BK; Leblanc CA; Jónsson Z; Öhlund G; Smith C; Snorrason SS Biol Rev Camb Philos Soc; 2019 Oct; 94(5):1786-1808. PubMed ID: 31215138 [TBL] [Abstract][Full Text] [Related]
13. Where is, in 2017, the evo in evo-devo (evolutionary developmental biology)? Diogo R J Exp Zool B Mol Dev Evol; 2018 Jan; 330(1):15-22. PubMed ID: 29393575 [TBL] [Abstract][Full Text] [Related]
14. Kowalevsky, comparative evolutionary embryology, and the intellectual lineage of evo-devo. Raff RA; Love AC J Exp Zool B Mol Dev Evol; 2004 Jan; 302(1):19-34. PubMed ID: 14760652 [TBL] [Abstract][Full Text] [Related]
15. How evolutionary principles improve the understanding of human health and disease. Gluckman PD; Low FM; Buklijas T; Hanson MA; Beedle AS Evol Appl; 2011 Mar; 4(2):249-63. PubMed ID: 25567971 [TBL] [Abstract][Full Text] [Related]
16. Low nephron endowment increases susceptibility to renal stress and chronic kidney disease. Good PI; Li L; Hurst HA; Serrano Herrera I; Xu K; Rao M; Bateman DA; Al-Awqati Q; D'Agati VD; Costantini F; Lin F JCI Insight; 2023 Feb; 8(3):. PubMed ID: 36626229 [TBL] [Abstract][Full Text] [Related]
17. Nephron mass as a risk factor for progression of renal disease. Brenner BM; Mackenzie HS Kidney Int Suppl; 1997 Dec; 63():S124-7. PubMed ID: 9407439 [TBL] [Abstract][Full Text] [Related]
18. An evolutionary medicine approach to understanding factors that contribute to chronic obstructive pulmonary disease. Aoshiba K; Tsuji T; Itoh M; Yamaguchi K; Nakamura H Respiration; 2015; 89(3):243-52. PubMed ID: 25677028 [TBL] [Abstract][Full Text] [Related]
19. Low nephron number and its clinical consequences. Luyckx VA; Shukha K; Brenner BM Rambam Maimonides Med J; 2011 Oct; 2(4):e0061. PubMed ID: 23908819 [TBL] [Abstract][Full Text] [Related]